MEPERIDINE Drug Patent Profile
✉ Email this page to a colleague
When do Meperidine patents expire, and what generic alternatives are available?
Meperidine is a drug marketed by Wyeth Ayerst, Abbott, Baxter Hlthcare, Igi Labs Inc, Intl Medication, Parke Davis, Watson Labs, West-ward Pharms Int, Hikma, Barr, Duramed Pharms Barr, Epic Pharma Llc, Genus, Specgx Llc, Strides Pharma Intl, Sun Pharm Inds Inc, Sun Pharm Industries, Hospira, and Icu Medical Inc. and is included in forty-three NDAs.
The generic ingredient in MEPERIDINE is meperidine hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the meperidine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Meperidine
A generic version of MEPERIDINE was approved as meperidine hydrochloride by HIKMA on January 30th, 1985.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MEPERIDINE?
- What are the global sales for MEPERIDINE?
- What is Average Wholesale Price for MEPERIDINE?
Summary for MEPERIDINE
| US Patents: | 0 |
| Applicants: | 19 |
| NDAs: | 43 |
| Drug Prices: | Drug price information for MEPERIDINE |
| DailyMed Link: | MEPERIDINE at DailyMed |
US Patents and Regulatory Information for MEPERIDINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epic Pharma Llc | MEPERIDINE HYDROCHLORIDE | meperidine hydrochloride | TABLET;ORAL | 040331-002 | May 28, 1999 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| West-ward Pharms Int | MEPERIDINE HYDROCHLORIDE | meperidine hydrochloride | INJECTABLE;INJECTION | 080455-009 | Approved Prior to Jan 1, 1982 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Specgx Llc | MEPERIDINE HYDROCHLORIDE | meperidine hydrochloride | TABLET;ORAL | 040352-002 | Jun 13, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
